Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Vein Isolation Alone or in Combination With Substrate Modulation After Electric Cardioversion Failure in Patients With Persistent Atrial Fibrillation: a Randomized, Multicentric, and Comparative Study

NCT05264831 is registered in ClinicalTrials.gov with Elsan as lead sponsor.

NCT NCT05264831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Vein Isolation Alone or in Combination With Substrate Modulation After Electric Cardioversion Failure in Patients With Persistent Atrial Fibrillation: a Randomized, Multicentric, and Comparative Study
Lead sponsor
Elsan
Phase
Not applicable
Overall status
Recruiting
Start date
February 20, 2023
Completion date
October 1, 2027
Enrollment
450 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation